Although hepatocellular carcinoma (HCC) is associated with a poor prognosis, management
of early-stage HCC is often successful with highly efficacious treatment modalities such as …

Introduction The aim of this study is to conduct a meta-analysis to assess the efficacy of
yttrium-90 selective internal radiation therapy (SIRT) in treating patients with breast cancer …

About 80% of hepatocellular carcinoma (HCC) patients are in advanced stages and
ineligible for curative surgery. Palliative treatments just maintained limited survival, thus an …

Cancer is one of the most important public health issues worldwide. Radiation therapy
(XRT), chemotherapy, and targeted therapy are some of the main types of cancer therapy …

Simple Summary Liver transplantation (LT) is the best potentially curative treatment for
unresectable, early-stage hepatocellular carcinoma (HCC) in cirrhotic patients. Bridging-to …

Hepatocellular carcinoma (HCC) is one of the most malignant tumors, the morbidity and
mortality of HCC ranked 6th and 3rd among all malignant tumors, respectively. Patients with …

Objectives To assess the cost-effectiveness of transarterial radioembolization (TARE) versus
conventional transarterial chemoembolization (cTACE) and drug-eluting beads …

Simple Summary Radioembolization (RE) for intrahepatic cholangiocarcinoma (ICC) is a
viable treatment option. As the overall survival (OS) is subject to considerable variance …

Objective: To date, there has been no study comparing transarterial chemoembolization
(TACE) with transarterial radioembolization (TARE) in these patients, so this study was …

Methods: A literature review of papers on this topic was performed using PubMed MEDLINE,
focusing exclusively on the role of yttrium-90 SIRT across all BCLC stages and comparing it …